Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin alfa for anemia associated with chronic obstructive pulmonary disease
2007-003153-90Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2007
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of darbepoetin alfa in anaemia and chronic obstructive pulmonary disease (COPD), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: 6-minute walk distance. Started Aug 2007; status: active.
02
Drugs
darbepoetin alfa
03
Conditions
anaemiachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2007-003153-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003153-90.